By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Lightlake Therapeutics Inc. 



London      United Kingdom
Phone: n/a Fax:


SEARCH JOBS








Company News
Lightlake Therapeutics Inc. (LLTP), Adapt Pharma Forge Deal Worth $55 Million 12/16/2014 9:17:03 AM
Lightlake Therapeutics Inc. (LLTP) Commences Trial For Treatment Of Opioid Overdose With The U.S. National Institute On Drug Abuse (NIDA) 12/4/2014 11:04:21 AM
Lightlake Therapeutics Inc. (LLTP) Announces Closing Of Investments In Two Products 10/2/2014 9:19:22 AM
Lightlake Therapeutics Inc. (LLTP) Receives Funding Commitment From A Prominent International Research And Development Foundation 7/30/2014 8:31:26 AM
Lightlake Therapeutics Inc. (LLTP) Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 7/23/2014 12:00:10 PM
Lightlake Therapeutics Inc. (LLTP) Signs Agreement With Commercial Contract Manufacturer For Its Opioid Overdose Reversal Treatment 7/9/2014 9:54:15 AM
Lightlake Therapeutics Inc. (LLTP) To Present At The Third Annual Marcum MicroCap Conference 5/22/2014 7:08:49 AM
Lightlake Therapeutics Inc. (LLTP) Chief Executive Officer Letter To Shareholders 12/20/2013 11:59:41 AM
Initial Data From Lightlake Therapeutics Inc. (LLTP) Joint Clinical Trial With National Institute on Drug Abuse (NIDA) Shows Nasal Delivery Of Naloxone For Opioid Overdose As A Promising Treatment 12/4/2013 11:10:42 AM
Lightlake Therapeutics Inc. (LLTP) To Present At 6th Annual LD MICRO Conference 11/20/2013 7:30:15 AM
1234
//-->